Related Experiment Video

Updated: Aug 9, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Effect of clotrimazole on Naegleria fowleri

A Jamieson

    Journal of Clinical Pathology
    |June 1, 1975
    PubMed

    Insights

    Clotrimazole showed low efficacy against Naegleria fowleri in vitro and did not protect mice from infection. Further research is needed to find effective treatments for Naegleria fowleri.

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Naegleria fowleri is a free-living amoeba that causes primary amoebic meningoencephalitis (PAM), a rare but often fatal brain infection.
    • Current treatment options for PAM are limited, highlighting the need for novel therapeutic agents.

    Purpose of the Study:

    • To evaluate the in vitro and in vivo efficacy of clotrimazole against Naegleria fowleri.

    Main Methods:

    • Testing the sensitivity of 18 Naegleria fowleri strains to clotrimazole, determining minimal inhibitory concentrations (MICs) and minimal amoebicidal concentrations (MACs).
    • Assessing clotrimazole's protective effect in a mouse model of Naegleria fowleri infection, with daily drug administration post-inoculation.
    • Measuring serum clotrimazole levels in mice to understand drug pharmacokinetics.

    Main Results:

    • Clotrimazole demonstrated low-level inhibitory and amoebicidal activity against Naegleria fowleri in vitro, with MICs ranging from 0.03-0.125 µg/ml and MACs from 0.125-0.25 µg/ml.
    • Mice infected with Naegleria fowleri and treated with clotrimazole (100 mg/kg/day for five days) showed no protection from infection.
    • Achieved serum clotrimazole levels in mice reached up to 6 µg/ml within 32 hours post-inoculation.

    Conclusions:

    • Clotrimazole exhibits limited in vitro activity against Naegleria fowleri.
    • Clotrimazole is ineffective in protecting mice against Naegleria fowleri infection, despite achieving detectable serum levels.

    More Related Videos

    Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks09:18

    Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

    Published on: December 2, 2022

    Transfection of a Molecular Clone of Naegleria gruberi rDNA into N. gruberi Trophozoites06:55

    Transfection of a Molecular Clone of Naegleria gruberi rDNA into N. gruberi Trophozoites

    Published on: June 21, 2024

    Related Concept Videos

    Antimicrobial Effectiveness01:28

    Antimicrobial Effectiveness

    The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Giardiasis01:12

    Giardiasis

    Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
    Candidiasis01:20

    Candidiasis

    Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...